Cargando…

Integrating Intrinsic Radiosensitivity and Immune Status for Predicting Benefits of Radiotherapy in Head and Neck Squamous Cell Carcinoma

BACKGROUND: HNSCC (head and neck squamous cell carcinoma) is a heterogeneous disease for which radiotherapy is a main treatment. As intrinsic radiosensitivity and immune status affect the initial and effective stage of the radiation-induced cancer immunity cycle, respectively, it is important to con...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Chuyao, Zhang, Miao, Qiao, Qiao, Wang, Yanli
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Scientific Literature, Inc. 2021
Materias:	Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8547194/ https://www.ncbi.nlm.nih.gov/pubmed/34670999 http://dx.doi.org/10.12659/MSM.932126

Ejemplares similares

Antisense inhibition of ATM gene enhances the radiosensitivity of head and neck squamous cell carcinoma in mice
por: Zou, Jian, et al.
Publicado: (2008)

Zerumbone acts as a radiosensitizer in head and neck squamous cell carcinoma
por: Schnoell, Julia, et al.
Publicado: (2021)

PD-1 and PD-L1 Expression Predicts Radiosensitivity and Clinical Outcomes in Head and Neck Cancer and is Associated with HPV Infection
por: Lyu, Xintong, et al.
Publicado: (2019)

Radiosensitization approaches for HPV‐positive and HPV‐negative head and neck squamous carcinomas
por: Dok, Rüveyda, et al.
Publicado: (2019)

Photodynamic Therapy as a Potent Radiosensitizer in Head and Neck Squamous Cell Carcinoma
por: Cho, Won Jin, et al.
Publicado: (2021)

PI3k inhibitors (BKM120 and BYL719) as radiosensitizers for head and neck squamous cell carcinoma during radiotherapy
por: Chuang, Fu-Cheng, et al.
Publicado: (2021)

Immune checkpoint pathways in immunotherapy for head and neck squamous cell carcinoma
por: Mei, Zi, et al.
Publicado: (2020)

In vitro and in vivo superior radiosensitizing effect of berbamine for head and neck squamous cell carcinoma
por: Zhu, Hongmei, et al.
Publicado: (2018)

Prediction of Radiosensitivity in Head and Neck Squamous Cell Carcinoma Based on Multiple Omics Data
por: Liu, Jie, et al.
Publicado: (2020)

MiR-125 family improves the radiosensitivity of head and neck squamous cell carcinoma
por: Wang, Qi-Wei, et al.
Publicado: (2023)

Intrinsic radiosensitivity and prediction of patient response to radiotherapy for carcinoma of the cervix.
por: West, C. M., et al.
Publicado: (1993)

The in vitro radiosensitivity of human head and neck cancers.
por: BjÃ¶rk-Eriksson, T., et al.
Publicado: (1998)

MUC1 as a target for CAR‐T therapy in head and neck squamous cell carinoma
por: Mei, Zi, et al.
Publicado: (2019)

Multi-Omics Integration Reveals the Crucial Role of Fusobacterium in the Inflammatory Immune Microenvironment in Head and Neck Squamous Cell Carcinoma
por: Qiao, Han, et al.
Publicado: (2022)

The Small Molecule Inhibitor QLT0267 Radiosensitizes Squamous Cell Carcinoma Cells of the Head and Neck
por: Eke, Iris, et al.
Publicado: (2009)

Enhancing radiosensitization in EphB4 receptor-expressing Head and Neck Squamous Cell Carcinomas
por: Bhatia, Shilpa, et al.
Publicado: (2016)

Afatinib radiosensitizes head and neck squamous cell carcinoma cells by targeting cancer stem cells
por: Macha, Muzafar A, et al.
Publicado: (2017)

Gene signature for prediction of radiosensitivity in human papillomavirus-negative head and neck squamous cell carcinoma
por: Kim, Su Il, et al.
Publicado: (2020)

Tyrosine Kinase c-MET as Therapeutic Target for Radiosensitization of Head and Neck Squamous Cell Carcinomas
por: Lüttich, Lina, et al.
Publicado: (2021)

Proton Radiotherapy to Reduce Late Complications in Childhood Head and Neck Cancers
por: Spiotto, Michael T., et al.
Publicado: (2021)

Intrinsic Radiosensitivity Is Not the Determining Factor in Treatment Response Differences between HPV Negative and HPV Positive Head and Neck Cancers
por: Reid, Paul, et al.
Publicado: (2020)

Radiotherapy Quality Assurance for Head and Neck Squamous Cell Carcinoma
por: Van Gestel, Dirk, et al.
Publicado: (2020)

Blood transfusion during radical chemo-radiotherapy does not reduce tumour hypoxia in squamous cell cancer of the head and neck
por: Welsh, Liam, et al.
Publicado: (2017)

A radiosensitivity MiRNA signature validated by the TCGA database for head and neck squamous cell carcinomas
por: Liu, Ning, et al.
Publicado: (2015)

Caspase-8 loss radiosensitizes head and neck squamous cell carcinoma to SMAC mimetic–induced necroptosis
por: Uzunparmak, Burak, et al.
Publicado: (2020)

Effectiveness of PARP inhibition in enhancing the radiosensitivity of 3D spheroids of head and neck squamous cell carcinoma
por: Zhou, Chumin, et al.
Publicado: (2022)

HMGB1 in Radiotherapy: A Two Headed Signal Regulating Tumor Radiosensitivity and Immunity
por: Liao, Yin, et al.
Publicado: (2020)

Immune-related miRNA signature identifies prognosis and immune landscape in head and neck squamous cell carcinomas
por: Ma, Bo, et al.
Publicado: (2020)

Clinical-genomic determinants of immune checkpoint blockade response in head and neck squamous cell carcinoma
por: Valero, Cristina, et al.
Publicado: (2023)

Genotyping and Characterization of HPV Status, Hypoxia, and Radiosensitivity in 22 Head and Neck Cancer Cell Lines
por: Göttgens, Eva-Leonne, et al.
Publicado: (2021)

An immune‐related seven‐lncRNA signature for head and neck squamous cell carcinoma
por: Chen, Yue, et al.
Publicado: (2021)

Construction and validation of a prognostic nine-gene signature associated with radiosensitivity in head and neck squamous cell carcinoma
por: Lu, Congxian, et al.
Publicado: (2023)

Prediction of radiotherapy response with a 5‐microRNA signature‐based nomogram in head and neck squamous cell carcinoma
por: Chen, Lin, et al.
Publicado: (2018)

Outcomes of Recurrent Head and Neck Cutaneous Squamous Cell Carcinoma
por: Dean, Nichole R., et al.
Publicado: (2011)

Bleeding complications in patients with squamous cell carcinoma of the head and neck
por: Bergamini, Cristiana, et al.
Publicado: (2021)

Nivolumab and ipilimumab in combination with radiotherapy in patients with high-risk locally advanced squamous cell carcinoma of the head and neck
por: Johnson, Jennifer M, et al.
Publicado: (2023)

Noncanonical HPV carcinogenesis drives radiosensitization of head and neck tumors
por: Schrank, Travis P., et al.
Publicado: (2023)

An Inflammation-Immunity Classifier of 11 Chemokines for Prediction of Overall Survival in Head and Neck Squamous Cell Carcinoma
por: Liang, Yushan, et al.
Publicado: (2019)

Immune Cluster and PPI Network Analyses Identified CXCR3 as a Key Node of Immunoregulation in Head and Neck Cancer
por: Wang, Ping, et al.
Publicado: (2021)

Nutrition intervention is beneficial in oncology outpatients receiving radiotherapy to the gastrointestinal or head and neck area
por: Isenring, E A, et al.
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_kjahi2vo2bf1mpbi0jcvp6rqsd